FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1853997079> ?p ?o ?g. }

• W1853997079 endingPage "460" @default.
• W1853997079 startingPage "452" @default.
• W1853997079 abstract "Objective To investigate transient receptor potential vanilloid 4 (TRPV4) expression in bladder afferents and study the effect of TRPV4 and TRPV1 antagonists, alone and in combination, in bladder hyperactivity and pain induced by cystitis. Material and Methods TRPV4 expression in bladder afferents was analysed by immunohistochemistry in L6 dorsal root ganglia (DRG), labelled by fluorogold injected in the urinary bladder. TRPV4 and TRPV1 co-expression was also investigated in L6 DRG neurones of control rats and in rats with lipopolysaccharide (LPS)-induced cystitis. The effect of TRPV4 antagonist RN1734 and TRPV1 antagonist SB366791 on bladder hyperactivity and pain induced by cystitis was assessed by cystometry and visceral pain behaviour tests, respectively. Results TRPV4 is expressed in sensory neurones that innervate the urinary bladder. TRPV4-positive bladder afferents represent a different population than the TRPV1-expressing bladder afferents, as their co-localisation was minimal in control and inflamed rats. While low doses of RN1734 and SB366791 (176.7 ng/kg and 143.9 ng/kg, respectively) had no effect on bladder activity, the co-administration of the two totally reversed bladder hyperactivity induced by LPS. In these same doses, the antagonists partially reversed bladder pain behaviour induced by cystitis. Conclusions TRPV4 and TRPV1 are present in different bladder afferent populations. The synergistic activity of antagonists for these receptors in very low doses may offer the opportunity to treat lower urinary tract symptoms while minimising the potential side-effects of each drug." @default.
• W1853997079 created "2016-06-24" @default.
• W1853997079 creator A5004964502 @default.
• W1853997079 creator A5022192075 @default.
• W1853997079 creator A5031542604 @default.
• W1853997079 creator A5033203148 @default.
• W1853997079 creator A5066120645 @default.
• W1853997079 creator A5075462647 @default.
• W1853997079 date "2015-01-26" @default.
• W1853997079 modified "2023-09-27" @default.
• W1853997079 title "Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis" @default.
• W1853997079 cites W1963531856 @default.
• W1853997079 cites W1964852121 @default.
• W1853997079 cites W1973003628 @default.
• W1853997079 cites W1978275908 @default.
• W1853997079 cites W1984530749 @default.
• W1853997079 cites W1985404356 @default.
• W1853997079 cites W1988375390 @default.
• W1853997079 cites W2008217956 @default.
• W1853997079 cites W2017445997 @default.
• W1853997079 cites W2024424546 @default.
• W1853997079 cites W2025644518 @default.
• W1853997079 cites W2040501484 @default.
• W1853997079 cites W2050663388 @default.
• W1853997079 cites W2058046631 @default.
• W1853997079 cites W2070056663 @default.
• W1853997079 cites W2071657406 @default.
• W1853997079 cites W2082835429 @default.
• W1853997079 cites W2083484726 @default.
• W1853997079 cites W2090592412 @default.
• W1853997079 cites W2094323845 @default.
• W1853997079 cites W2097142746 @default.
• W1853997079 cites W2124906522 @default.
• W1853997079 cites W2134182567 @default.
• W1853997079 cites W2143444946 @default.
• W1853997079 cites W2148759073 @default.
• W1853997079 cites W2154105016 @default.
• W1853997079 cites W2155398460 @default.
• W1853997079 cites W2162643873 @default.
• W1853997079 cites W27153253 @default.
• W1853997079 doi "https://doi.org/10.1111/bju.12861" @default.
• W1853997079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25041193" @default.
• W1853997079 hasPublicationYear "2015" @default.
• W1853997079 type Work @default.
• W1853997079 sameAs 1853997079 @default.
• W1853997079 citedByCount "23" @default.
• W1853997079 countsByYear W18539970792015 @default.
• W1853997079 countsByYear W18539970792016 @default.
• W1853997079 countsByYear W18539970792017 @default.
• W1853997079 countsByYear W18539970792018 @default.
• W1853997079 countsByYear W18539970792019 @default.
• W1853997079 countsByYear W18539970792020 @default.
• W1853997079 countsByYear W18539970792021 @default.
• W1853997079 countsByYear W18539970792022 @default.
• W1853997079 countsByYear W18539970792023 @default.
• W1853997079 crossrefType "journal-article" @default.
• W1853997079 hasAuthorship W1853997079A5004964502 @default.
• W1853997079 hasAuthorship W1853997079A5022192075 @default.
• W1853997079 hasAuthorship W1853997079A5031542604 @default.
• W1853997079 hasAuthorship W1853997079A5033203148 @default.
• W1853997079 hasAuthorship W1853997079A5066120645 @default.
• W1853997079 hasAuthorship W1853997079A5075462647 @default.
• W1853997079 hasConcept C126322002 @default.
• W1853997079 hasConcept C142724271 @default.
• W1853997079 hasConcept C155164980 @default.
• W1853997079 hasConcept C160145004 @default.
• W1853997079 hasConcept C163146387 @default.
• W1853997079 hasConcept C170493617 @default.
• W1853997079 hasConcept C204787440 @default.
• W1853997079 hasConcept C2776354303 @default.
• W1853997079 hasConcept C2776885963 @default.
• W1853997079 hasConcept C2777540882 @default.
• W1853997079 hasConcept C2778122271 @default.
• W1853997079 hasConcept C2778508898 @default.
• W1853997079 hasConcept C2778941218 @default.
• W1853997079 hasConcept C2779762690 @default.
• W1853997079 hasConcept C2910041100 @default.
• W1853997079 hasConcept C71924100 @default.
• W1853997079 hasConcept C77411442 @default.
• W1853997079 hasConcept C90420996 @default.
• W1853997079 hasConcept C98274493 @default.
• W1853997079 hasConceptScore W1853997079C126322002 @default.
• W1853997079 hasConceptScore W1853997079C142724271 @default.
• W1853997079 hasConceptScore W1853997079C155164980 @default.
• W1853997079 hasConceptScore W1853997079C160145004 @default.
• W1853997079 hasConceptScore W1853997079C163146387 @default.
• W1853997079 hasConceptScore W1853997079C170493617 @default.
• W1853997079 hasConceptScore W1853997079C204787440 @default.
• W1853997079 hasConceptScore W1853997079C2776354303 @default.
• W1853997079 hasConceptScore W1853997079C2776885963 @default.
• W1853997079 hasConceptScore W1853997079C2777540882 @default.
• W1853997079 hasConceptScore W1853997079C2778122271 @default.
• W1853997079 hasConceptScore W1853997079C2778508898 @default.
• W1853997079 hasConceptScore W1853997079C2778941218 @default.
• W1853997079 hasConceptScore W1853997079C2779762690 @default.
• W1853997079 hasConceptScore W1853997079C2910041100 @default.
• W1853997079 hasConceptScore W1853997079C71924100 @default.
• W1853997079 hasConceptScore W1853997079C77411442 @default.

• next